Byrne Mark John 4
4 · Univar Inc. · Filed Dec 14, 2017
Insider Transaction Report
Form 4
Univar Inc.UNVR
Byrne Mark John
Director
Transactions
- Sale
Common Stock
2017-12-12$29.16/sh−49,500$1,443,643→ 14,494 total - Sale
Common Stock
2017-12-13$29.10/sh−40,534$1,179,357→ 14,494 total - Exercise/Conversion
Stock Options (right to buy)
2017-12-12−49,500→ 202,453 totalExercise: $18.54From: 2014-02-01Exp: 2024-02-01→ Common Stock (49,500 underlying) - Exercise/Conversion
Common Stock
2017-12-12$18.54/sh+49,500$917,730→ 63,994 total - Exercise/Conversion
Common Stock
2017-12-13$18.54/sh+40,534$751,500→ 55,028 total - Exercise/Conversion
Stock Options (right to buy)
2017-12-13−40,534→ 161,919 totalExercise: $18.54From: 2014-02-01Exp: 2024-02-01→ Common Stock (40,534 underlying)
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.061 to $29.365, inclusive. The Reporting Person understakes to provide Univar Inc., any of its security holders, or the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each seperate price within the range set forth in footnotes (1) and (2) to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.97 to $29.215, inclusive.
- [F3]These options were granted on February 1, 2014 and became vested and exercisable in 12 installments beginning on the grant date and ending on Decemember 28, 2014.